130 related articles for article (PubMed ID: 14963351)
1. Examination of tumorigenesis of precursor lesions in bladder cancer by in situ hybridization.
Krause S; Feil G; Beiter T; Pressler H; Schrott KM; Bichler KH
Urol Int; 2004; 72(2):118-22. PubMed ID: 14963351
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.
Hartmann A; Schlake G; Zaak D; Hungerhuber E; Hofstetter A; Hofstaedter F; Knuechel R
Cancer Res; 2002 Feb; 62(3):809-18. PubMed ID: 11830537
[TBL] [Abstract][Full Text] [Related]
3. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].
Shou J; Wang M; Ma J
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive detection of alterations in chromosome numbers in urinary bladder cancer cells, using fluorescence in situ hybridization.
Okamura T; Umemoto Y; Yasui T; Saiki S; Kuroda H; Kotoh S; Kamizaki H
Int J Clin Oncol; 2004 Oct; 9(5):373-7. PubMed ID: 15549587
[TBL] [Abstract][Full Text] [Related]
5. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
[TBL] [Abstract][Full Text] [Related]
6. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
[TBL] [Abstract][Full Text] [Related]
7. Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei.
Wheeless LL; Reeder JE; Han R; O'Connell MJ; Frank IN; Cockett AT; Hopman AH
Cytometry; 1994 Dec; 17(4):319-26. PubMed ID: 7875039
[TBL] [Abstract][Full Text] [Related]
8. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
Asali MG; Kaneti J; Manor E
Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
[TBL] [Abstract][Full Text] [Related]
9. Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations.
Zhang FF; Arber DA; Wilson TG; Kawachi MH; Slovak ML
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2317-28. PubMed ID: 9815630
[TBL] [Abstract][Full Text] [Related]
10. Correlation between histologic findings and cytogenetic abnormalities in bladder carcinoma: a FISH study.
Placer J; Espinet B; Salido M; Solé F; Gelabert-Mas A
Urology; 2005 May; 65(5):913-8. PubMed ID: 15882723
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.
Obermann EC; Meyer S; Hellge D; Zaak D; Filbeck T; Stoehr R; Hofstaedter F; Hartmann A; Knuechel R
Oncol Rep; 2004 Apr; 11(4):745-51. PubMed ID: 15010867
[TBL] [Abstract][Full Text] [Related]
12. Numerical aberrations of chromosomes 9 and 11 detected by FISH in Greek bladder cancer patients.
Panani AD; Babanaraki A; Malianga E; Roussos Ch
Anticancer Res; 2004; 24(6):3857-61. PubMed ID: 15736422
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal aneuploidy precedes morphological changes and supports multifocality in head and neck lesions.
Ai H; Barrera JE; Meyers AD; Shroyer KR; Varella-Garcia M
Laryngoscope; 2001 Oct; 111(10):1853-8. PubMed ID: 11801957
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal numerical aberrations detected by fluorescence in situ hybridization on bladder washings from patients with bladder cancer.
Marano A; Pan Y; Li C; Pagliarulo A; Elmberger G; Tribukait B; Ekman P; Bergerheim U
Eur Urol; 2000 Mar; 37(3):358-65. PubMed ID: 10720866
[TBL] [Abstract][Full Text] [Related]
15. Identification of chromosome 9 alterations and p53 accumulation in isolated carcinoma in situ of the urinary bladder versus carcinoma in situ associated with carcinoma.
Hopman AH; Kamps MA; Speel EJ; Schapers RF; Sauter G; Ramaekers FC
Am J Pathol; 2002 Oct; 161(4):1119-25. PubMed ID: 12368185
[TBL] [Abstract][Full Text] [Related]
16. Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer.
Yamamoto Y; Matsuyama H; Furuya T; Oga A; Yoshihiro S; Okuda M; Kawauchi S; Sasaki K; Naito K
Clin Cancer Res; 2004 Oct; 10(19):6449-55. PubMed ID: 15475431
[TBL] [Abstract][Full Text] [Related]
17. Two molecular pathways to transitional cell carcinoma of the bladder.
Spruck CH; Ohneseit PF; Gonzalez-Zulueta M; Esrig D; Miyao N; Tsai YC; Lerner SP; Schmütte C; Yang AS; Cote R
Cancer Res; 1994 Feb; 54(3):784-8. PubMed ID: 8306342
[TBL] [Abstract][Full Text] [Related]
18. Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization.
Hopman AH; Moesker O; Smeets AW; Pauwels RP; Vooijs GP; Ramaekers FC
Cancer Res; 1991 Jan; 51(2):644-51. PubMed ID: 1985781
[TBL] [Abstract][Full Text] [Related]
19. Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development.
Zieger K; Marcussen N; Borre M; Ørntoft TF; Dyrskjøt L
Int J Cancer; 2009 Nov; 125(9):2095-103. PubMed ID: 19637316
[TBL] [Abstract][Full Text] [Related]
20. Molecular cytogenetic characterization and diagnostics of bladder cancer.
Houskova L; Zemanova Z; Babjuk M; Melichercikova J; Pesl M; Michalova K
Neoplasma; 2007; 54(6):511-6. PubMed ID: 17949235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]